𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effectiveness of Adjuvant Tamoxifen Therapy among Older Women with Early Stage Breast Cancer

✍ Scribed by Cynthia Owusu; Timothy L. Lash; Rebecca A. Silliman

Book ID
109079535
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
538 KB
Volume
13
Category
Article
ISSN
1075-122X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Risk of early recurrence among postmenop
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen
✍ Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 162 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)‐positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi

Completion of adjuvant radiation therapy
Completion of adjuvant radiation therapy among women with breast cancer
✍ Tomasz P. Srokowski; Shenying Fang; Zhigang Duan; Thomas A. Buchholz; Gabriel N. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Optimal treatment for breast cancer often involves lengthy multimodality care including 5 to 6 weeks of radiotherapy, but few studies have evaluated adherence to radiotherapy outside the context of a therapeutic clinical trial. ## METHODS. Using a SEER‐Medicare databas

Excellent outcomes with adjuvant toremif
Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer
✍ Jaime D. Lewis; Anees B. Chagpar; Elizabeth A. Shaughnessy; Jacob Nurko; Kelly M πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 184 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: Fareston (toremifene) and tamoxifen, both selective estrogen receptor modulators, are therapeutically equivalent treatments for metastatic breast cancer. We hypothesized that toremifene as compared with tamoxifen given as adjuvant therapy for early stage breast cancer wo